University Hospital Tuebingen
Clinical trials sponsored by University Hospital Tuebingen, explained in plain language.
-
Sheep Virus-Based COVID booster enters human trials
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new type of COVID-19 booster vaccine made from a harmless sheep virus. It aims to see if it is safe and boosts immunity in 96 healthy adults aged 18 to 55 who have already been vaccinated or infected. The vaccine is given as a single booster shot, and participa…
Phase: PHASE1 • Sponsor: University Hospital Tuebingen • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 26, 2026 20:03 UTC
-
New vaccine targets rare liver Cancer's genetic weakness
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial tests a vaccine designed to help the immune system recognize and attack cancer cells that carry a specific genetic change (DNAJB1-PRKACA fusion). The study includes up to 20 people with fibrolamellar hepatocellular carcinoma or other cancers with this same …
Phase: PHASE1 • Sponsor: University Hospital Tuebingen • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 26, 2026 20:00 UTC
-
Robot surgery may slash complication rates in penile cancer groin procedure
Disease control Recruiting nowThis study tests whether robot-assisted surgery to remove groin lymph nodes in penile cancer patients causes fewer serious complications than standard open surgery. About 80 men with penile cancer who need this procedure will be randomly assigned to one of the two approaches. The…
Phase: NA • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC